Jim Cramer Discussed These 21 Stocks As Bond Yields Soared

Page 14 of 19

6. Merck & Co., Inc. (NYSE:MRK)

Number of Hedge Fund Holders In Q3 2024: 86

Merck & Co., Inc. (NYSE:MRK) is one of the largest pharmaceutical companies in the world. Over the past couple of years, the firm has managed to set itself apart from others primarily through its cancer vaccine KEYTRUDA. KEYTRUDA is one of the most widely sold and popular cancer vaccines in the world. 2025 has also been a good year so far for Merck & Co., Inc. (NYSE:MRK) after the firm’s shares soared by 2.3% after the firm bought an Irish vaccine facility owned by a Chinese firm. Cramer, however, commented on Merck & Co., Inc. (NYSE:MRK)’s slow share performance:

“Merck is getting pummeled. Pummeled. Look at Merck!

“Even though GARDASIL just got the expanded approval I’ve been waiting for males in China for ages.”

Page 14 of 19